Challenges of the management of severe hemophilia A with inhibitors: two case reports emphasizing the potential interest of a high-purity human Factor VIII/von Willebrand factor concentrate and individually tailored prophylaxis guided by thrombin-generation test.

MLA

Mathieu, Sophie, et al. “Challenges of the Management of Severe Hemophilia A with Inhibitors: Two Case Reports Emphasizing the Potential Interest of a High-Purity Human Factor VIII/von Willebrand Factor Concentrate and Individually Tailored Prophylaxis Guided by Thrombin-Generation Test.” Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis, vol. 26, no. 8, Dec. 2015, pp. 940–45. EBSCOhost, https://doi.org/10.1097/MBC.0000000000000300.

APA

Mathieu, S., Crampe, C., Dargaud, Y., Lavigne-Lissalde, G., Escuriola-Ettingshausen, C., Tardy, B., Meley, R., Thouvenin, S., Stephan, J. L., & Berger, C. (2015). Challenges of the management of severe hemophilia A with inhibitors: two case reports emphasizing the potential interest of a high-purity human Factor VIII/von Willebrand factor concentrate and individually tailored prophylaxis guided by thrombin-generation test. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis, 26(8), 940–945. https://doi.org/10.1097/MBC.0000000000000300

Chicago

Mathieu, Sophie, Carine Crampe, Yesim Dargaud, Géraldine Lavigne-Lissalde, Carmen Escuriola-Ettingshausen, Brigitte Tardy, Roland Meley, Sandrine Thouvenin, Jean L Stephan, and Claire Berger. 2015. “Challenges of the Management of Severe Hemophilia A with Inhibitors: Two Case Reports Emphasizing the Potential Interest of a High-Purity Human Factor VIII/von Willebrand Factor Concentrate and Individually Tailored Prophylaxis Guided by Thrombin-Generation Test.” Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis 26 (8): 940–45. doi:10.1097/MBC.0000000000000300.